Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis

Clinical trial NCT01563185 · COMPLETED

Trial details

NCT number: NCT01563185
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Juvenile Idiopathic Arthritis

Start date: 2012-04-01
Primary completion: 2015-03-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.